Finland· FI-REL-REL52958
Sympagesic
A butyyliskopolamiini ja analgeetti product containing metamizole sodium monohydrate + hyoscine butylbromide, registered in Finland by Dechra Regulatory B.V.. The same ATC class is registered in 2 of our 19 countries.
Checked against Fimea (Finland) on
Informational only — not a medical device.
Where it is registered
Metamizole sodium monohydrate + hyoscine butylbromide is registered in 2 of 19 countries.
Countries holding a registration under ATC QA03DB04 (butyyliskopolamiini ja analgeetti), each read from that country’s own register.
- This record: Finland, from Fimea (Finland)
- 1 of them publish a price we can compare per daily dose
Metamizole sodium monohydrate + hyoscine butylbromide · ATC QA03DB04
2 / 19 countries
- Denmark
- Finlandprice
The record
At a glance
Fimea (Finland)- Active substance
- Metamizole sodium monohydrate + Hyoscine butylbromide
- Manufacturer
- Dechra Regulatory B.V.
- Country
- Finland (FI)
- ATC code
- QA03DB04
- ATC class
- Butyyliskopolamiini ja analgeetti
- Reimbursed
- Not published by this register
- Source register
- Fimea (Finland)
- Last checked
- September 27, 2026
Packs & prices · 0
No packs listed by the register for this record.
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same class
Other records under QA03DB04
Butyyliskopolamiini ja analgeetti, as other registers publish it.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Fimea (Finland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/83938f41-878b-42f4-ab5c-a4e919a10141 GET /v1/drugs/83938f41-878b-42f4-ab5c-a4e919a10141?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"ddd": null,
"form": "injektioneste, liuos",
"route": "Laskimoon",
"ddd_unit": null,
"strength": "500 mg/ml / 4 mg/ml",
"atc_label": "Butyyliskopolamiini ja analgeetti",
"ma_number": "36145",
"auth_status": "Myyntilupa myönnetty",
"eu_ma_number": null,
"fimea_rel_id": "REL52958",
"authorised_at": "2020-08-31"
}See everything about metamizole sodium monohydrate + hyoscine butylbromide.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.